A detailed history of Banco De Sabadell, S.A transactions in Novartis Ag stock. As of the latest transaction made, Banco De Sabadell, S.A holds 7,116 shares of NVS stock, worth $700,570. This represents 0.61% of its overall portfolio holdings.

Number of Shares
7,116
Previous 8,307 14.34%
Holding current value
$700,570
Previous $879,000 6.94%
% of portfolio
0.61%
Previous 0.64%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $126,400 - $143,979
-1,191 Reduced 14.34%
7,116 $818,000
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $16,847 - $19,541
182 Added 2.24%
8,307 $879,000
Q1 2024

May 13, 2024

SELL
$95.27 - $108.47 $2,953 - $3,362
-31 Reduced 0.38%
8,125 $789,000
Q4 2023

Feb 09, 2024

SELL
$92.27 - $101.54 $1,937 - $2,132
-21 Reduced 0.26%
8,156 $824,000
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $28,040 - $31,118
-296 Reduced 3.49%
8,177 $832,000
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $4,070 - $4,616
-44 Reduced 0.52%
8,473 $854,000
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $66,264 - $76,846
828 Added 10.77%
8,517 $787,000
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $113,249 - $138,687
1,499 Added 24.22%
7,689 $701,000
Q3 2022

Nov 10, 2022

SELL
$74.61 - $87.26 $63,194 - $73,909
-847 Reduced 12.04%
6,190 $469,000
Q2 2022

Aug 11, 2022

SELL
$80.52 - $93.75 $14,896 - $17,343
-185 Reduced 2.56%
7,037 $593,000
Q1 2022

May 12, 2022

BUY
$80.11 - $90.62 $42,938 - $48,572
536 Added 8.02%
7,222 $631,000
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $51,087 - $56,491
641 Added 10.6%
6,686 $579,000
Q3 2021

Nov 04, 2021

SELL
$81.78 - $95.14 $27,150 - $31,586
-332 Reduced 5.21%
6,045 $492,000
Q2 2021

Aug 13, 2021

BUY
$85.24 - $94.15 $36,738 - $40,578
431 Added 7.25%
6,377 $581,000
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $9,936 - $11,717
-119 Reduced 1.96%
5,946 $507,000
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $30,291 - $36,638
388 Added 6.83%
6,065 $574,000
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $14,128 - $15,652
172 Added 3.12%
5,677 $493,000
Q2 2020

Aug 07, 2020

SELL
$80.93 - $91.1 $54,061 - $60,854
-668 Reduced 10.82%
5,505 $481,000
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $2.46 Million - $3.44 Million
-34,772 Reduced 84.92%
6,173 $504,000
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $665,352 - $752,278
-7,888 Reduced 16.15%
40,945 $3.88 Million
Q3 2019

Nov 15, 2019

SELL
$85.54 - $94.26 $555,154 - $611,747
-6,490 Reduced 11.73%
48,833 $4.25 Million
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $252,062 - $310,230
3,343 Added 6.43%
55,323 $5.05 Million
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $116,294 - $133,015
1,544 Added 3.06%
51,980 $4.98 Million
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $2.92 Million - $3.25 Million
39,588 Added 364.93%
50,436 $4.31 Million
Q3 2018

Nov 16, 2018

SELL
$66.94 - $77.43 $3,480 - $4,026
-52 Reduced 0.48%
10,848 $932,000
Q2 2018

Aug 15, 2018

SELL
$64.91 - $73.36 $1,103 - $1,247
-17 Reduced 0.16%
10,900 $828,000
Q1 2018

May 16, 2018

BUY
$70.39 - $84.15 $86,579 - $103,504
1,230 Added 12.7%
10,917 $883,000
Q4 2017

Feb 16, 2018

BUY
$72.33 - $77.64 $700,660 - $752,098
9,687
9,687 $813,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Banco De Sabadell, S.A Portfolio

Follow Banco De Sabadell, S.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.